Why Is MONTE ROSA THERAPEUT (GLUE) Stock Moving Today?
MONTE ROSA THERAPEUT (GLUE) is drawing unusual attention today.
Why GLUE stock is down today
Monte Rosa Therapeutics (GLUE) fell 5.86% to $10.60 in afternoon trading on October 2, 2026. The stock opened higher but reversed course after a wave of selling pressure emerged in the afternoon. Despite positive Phase 1 results for its lead candidate MRT-8102, the stock has struggled to maintain momentum following a sharp pre-market rally earlier in the week.
What Happened
Monte Rosa announced strong Phase 1 data for MRT-8102, a NEK7-directed molecular glue degrader, showing 80%, 90% NEK7 degradation and broad reductions in inflammatory markers. The GFORCE-1 study reported normalization of key pathogenic drivers of atherosclerotic cardiovascular disease (ASCVD) in subjects with elevated CVD risk. These findings were disclosed in a Form 8-K filing and covered in detail by multiple outlets including MarketWatch, Business Insider, and GlobeNewswire. H.C. Wainwright initiated coverage on the stock with a Buy rating and a $25 price target. However, the stock's sharp intraday reversal suggests investor skepticism or profit-taking after a 20% pre-market surge.
What The Data Shows
The stock opened at $11.24 and reached an intraday high of $11.40 at 9:30 AM ET before declining to a low of $10.59 at 1:35 PM ET. Trading volume of 0.7 million shares was 50% above the 3-month daily average. The stock closed at $10.61, down from its opening price. Over the last eight sessions, GLUE has declined 1.6% from $12.21 to $12.01. In the last 90 days, insiders have sold a total of $462,000 worth of shares, with the most recent transaction on July 17. The stock has hit 19 fresh 52-week lows on October 2.
What To Watch
Monte Rosa has no upcoming earnings date scheduled. Investors should monitor the breadth of analyst coverage and any follow-up data from the GFORCE-1 trial.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
GLUE by the numbers
The headlines behind the move
No wire coverage in the public window yet. Open the live terminal for the real-time tape.
More moves explained today
- Why is ACCV down today (-18.94%)
- Why is SVRA down today (-17.95%)
- Why is APLD down today (-17.45%)
- Why is AAOI down today (-16.14%)
- Why is CLS down today (-15.03%)
- Why is WOLF down today (-14.70%)
More on GLUE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier GLUE move explainers: 2026-10-02 · 2026-10-01